Biolinerx Ltd.-Spons ADRBLRX
13F holders, Q2 2025 (June 30)17holders +5
9new positions
4sold out
1famous investor
$4.56avg. 13F price*
At the end of Q2 2025, 17 institutions reported holding Biolinerx Ltd.-Spons ADR (BLRX) in their 13F filings, up 5 from Q1 2025. 9 opened new positions and 4 sold out. The largest holders were Citadel Advisors ($68K), Simplex Trading, LLC ($64K) and Two Sigma Securities, LLC ($63K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Biolinerx Ltd.-Spons ADR
- CUSIP
- 09071M304
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $266K |
| Exits | 4 | $7K |
All 13F filers, Q1 2025 → Q2 2025: 61,030 shares bought and 4,274 shares sold, net +56,756 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 17 holders
| Citadel Advisors | 0.00% | New | 14,954 | $68K |
| Simplex Trading, LLC | 0.00% | New | 14,114 | $64K |
| Two Sigma Securities, LLC | 0.01% | New | 13,816 | $63K |
| Susquehanna International Group, LLP | 0.00% | New | 11,098 | $51K |
| Rhumbline Advisers | 0.00% | Add +179.4% | 4,275 | $20K |
| Citigroup Inc. | 0.00% | New | 4,005 | $18K |
| Wells Fargo & Company | 0.00% | Reduce -41.7% | 1,750 | $8K |
| Morgan Stanley | 0.00% | Reduce -31.2% | 1,543 | $7K |
| Nemes Rush Group LLC | 0.00% | Reduce -16.7% | 250 | $1K |
| National Bank of Canada | 0.00% | New | 200 | $914 |
| NewEdge Advisors, LLC | 0.00% | No change | 107 | $489 |
| Raymond James Financial Inc. | 0.00% | New | 72 | $329 |
| Fifth Third Bancorp | 0.00% | New | 25 | $114 |
| Bank of America Corp. | 0.00% | No change | 2 | $9 |
| Danske Bank A/S | 0.00% | No change | 2 | $9 |
| SBI Securities Co., Ltd. | 0.00% | No change | 2 | $9 |
| Osaic Holdings, Inc. | 0.00% | New | 1 | $4 |
"% of holder's portfolio" is BLRX's weight in each manager's 13F, not the share of Biolinerx Ltd.-Spons ADR the manager owns.